Science Advisory Board
Reproductive Solutions advisory board members supply scientific and medical expertise to assist the company in its efforts to improve semen collection methodology as a means of improving outcomes for infertile couples. The board’s activities include interfacing directly with IVF/ART professionals at industry meetings, assisting in the development of educational and training materials, providing opportunities to observe ProteX implementation in their clinical practices, and offering strategic suggestions for advancing ProteX adoption based on their deep knowledge of the IVF/ART space. They will also share their insights on industry trends to help guide new product development.
Richard G. Rawlins, Ph.D., M.A., HCLD, ELD (ABB)
RSI Science Advisory Board Member
Dr. Rawlins has established 15 IVF/ART programs globally and is currently the Vice Chairman of the American Board of Bioanalysis in St. Louis, Missouri.
Read More
Juergen Liebermann, Ph.D., HCLD (ABB)
RSI Science Advisory Board Member
Dr. Liebermann is the Laboratory Director for Fertility Centers of Illinois (FCI) Chicago/River North Embryology, Andrology and the Endocrinology Lab.
Read More
Matthew (Tex) VerMilyea, Ph.D., HCLD/CC (ABB)
RSI Science Advisory Board Member
Dr. Matthew (Tex) VerMilyea is the Vice President of Scientific Advancement for Ovation Fertility.
Read More
Marc A. Brignola
RSI Science Advisory Board Member
Marc Brignola is the Global Vice President of Sales at Biotech Inc. with more than a decade of executive sales and marketing experience providing IVF/ART equipment to labs and fertility clinics worldwide.
Read More
Samuel Prien, Ph.D., HCLD (ABB)
RSI Science Advisor
Samuel Prien, Ph.D. is Director of Clinical and Research Laboratories and Professor in the Department of Obstetrics and Gynecology at Texas Tech University Health Sciences Center (TTUHSC).
Read More